CSTI yields 653.92% · JNJ yields 2.13%● Live data
📍 CSTI pulled ahead of the other in Year 1
Combined, CSTI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CSTI + JNJ for your $10,000?
Costar Technologies, Inc., together with its subsidiaries, engages in the design, development, manufacture, and distribution of security solution products in the United States. The company operates through three segments: Costar Video Systems, CostarHD, and Other. Its security solutions products include surveillance cameras, digital video recorders, lenses, and high-speed domes, as well as industrial vision products. The company also provides IP video solutions for traffic monitoring, security, surveillance, and military applications; and accessories, such as cables, camera mounts, and data storage devices. It provides its solutions for financial institutions, educational facilities, retail stores, manufacturing plants, highways, government buildings, military bases, borders, and other applications. The company was formerly known as Sielox, Inc. and changed its name to Costar Technologies, Inc. in October 2011. Costar Technologies, Inc. was incorporated in 1997 and is based in Coppell, Texas.
Full CSTI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.